Sfoglia per AUTORE
TASSONE F
Collezione AO Cuneo

  

Items : 13

Obesity in Prediabetic Patients: Management of Metabolic Complications and Strategies for Prevention of Overt Diabetes. in Endocrine, metabolic & immune disorders drug targets / Endocr Metab Immune Disord Drug Targets. 2025;25(1):8-36. doi: 10.2174/0118715303282327240507184902.
2025
AO Cuneo

Chianelli M; Armellini M; Carpentieri M; Coccaro C; Cuttica CM; Fusco A; Marucci S; Nelva A; Nizzoli M; Ponziani MC; Sciaraffia M; Tassone F; Busetto L;

Persistence of Elevated Procalcitonin in a Patient with Coronavirus Disease 2019 Uncovered a Diagnosis of Medullary Thyroid Carcinoma. in AACE clinical case reports / AACE Clin Case Rep. 2021 Sep-Oct;7(5):288-292. doi: 10.1016/j.aace.2021.05.001. Epub 2021 May 12.
2021
AO Cuneo

Gianotti L; D'Agnano S; Pettiti G; Tassone F; Giraudo G; Lauro C; Lauria G; Del Bono V; Borretta G; Gianotti L; D'Agnano S; Pettiti G; Tassone F; Giraudo G; Lauro C; Lauria G; Del Bono V; Borretta G;

Effects of a short-term alirocumab administration on the aortic stiffness: preliminary results. in Journal of geriatric cardiology : JGC / J Geriatr Cardiol. 2019 Oct;16(10):782-784. doi: 10.11909/j.issn.1671-5411.2019.10.001.
2019
AO Cuneo
ASL Cuneo 1

Tassone F; Marzia T; Gaetano R; Arianna R; Cinzia F; Mauro F;

Pheochromocytoma and Paraganglioma. in The New England journal of medicine / N Engl J Med. 2019 Nov 7;381(19):1882-1883. doi: 10.1056/NEJMc1912022.
2019
AO Cuneo

Tassone F;

Nivolumab-induced fulminant type 1 diabetes (T1D): the first Italian case report with long follow-up and flash glucose monitoring. in Acta diabetologica / Acta Diabetol. 2019 Apr;56(4):489-490. doi: 10.1007/s00592-018-1246-4. Epub 2018 Oct 25.
2019
AO Cuneo

Magro G; Baffoni C; Gianotti L; Gamarra E; Colantonio I; Tassone F; Borretta G;

Reduction of Insulin Requirement After Starting Treatment With Sacubitril/Valsartan in a Patient with Diabetes Treated With Continuous Subcutaneous Insulin Infusion (CSII): A case report. in Journal of diabetes science and technology / J Diabetes Sci Technol. 2018 Nov;12(6):1254-1255. doi: 10.1177/1932296818785644. Epub 2018 Jul 11.
2018
AO Cuneo
ASL Cuneo 1

Tassone F; Feola M; Borretta G; Baffoni C; Gamarra E;

Treating with liraglutide an obese patient with type 2 diabetes mellitus and hereditary hemochromatosis. in Minerva endocrinologica / Minerva Endocrinol. 2015 Dec;40(4):331-2. Epub 2015 Mar 24.
2015
AO Cuneo

Tassone F; Baffoni C; Gianotti L; Pellegrino M; Magro G; Cesario F; Maccario M; Borretta G;

Insulin sensitivity in normocalcaemic primary hyperparathyroidism. in Endocrine / Endocrine. 2013 Dec;44(3):812-4. doi: 10.1007/s12020-013-0059-z. Epub 2013 Sep 25.
2013
AO Cuneo

Tassone F; Maccario M; Gianotti L; Baffoni C; Pellegrino M; Cassibba S; Cesario F; Magro G; Borretta G;

Vitamin D status in primary hyperparathyroidism: a Southern European perspective. in Clinical endocrinology / Clin Endocrinol (Oxf). 2013 Dec;79(6):784-90. doi: 10.1111/cen.12210. Epub 2013 Apr 17.
2013
AO Cuneo

Tassone F; Gianotti L; Baffoni C; Visconti G; Pellegrino M; Cassibba S; Croce CG; Magro G; Cesario F; Attanasio R; Borretta G;

Prevalence and characteristics of metabolic syndrome in primary hyperparathyroidism. in Journal of endocrinological investigation / J Endocrinol Invest. 2012 Oct;35(9):841-6. doi: 10.3275/8192. Epub 2011 Dec 21.
2012
AO Cuneo

Tassone F; Gianotti L; Baffoni C; Cesario F; Magro G; Pellegrino M; Emmolo I; Maccario M; Borretta G;

[Renal function in primary hyperparathyroidism]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2010 Sep-Oct;27 Suppl 50:S91-5.
2010
AO Cuneo

Borretta G; Gianotti L; Cesario F; Borretta V; Tassone F;

Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism. in Diabetic medicine : a journal of the British Diabetic Association / Diabet Med. 2009 Oct;26(10):968-73. doi: 10.1111/j.1464-5491.2009.02804.x.
2009
AO Cuneo

Tassone F; Procopio M; Gianotti L; Visconti G; Pia A; Terzolo M; Borretta G;

A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2006 Aug;91(8):3011-6. doi: 10.1210/jc.2006-0070. Epub 2006 May 30.
2006
AO Cuneo

Gianotti L; Tassone F; Cesario F; Pia A; Razzore P; Magro G; Piovesan A; Borretta G;